HRES 928
119th Congress
House
In Committee
Affirming support for most-favored-Nation drug pricing for United States patients.
Latest action: Referred to the House Committee on Energy and Commerce. · Dec 4, 2025
View full text on Congress.gov ↗ Policy area: Health
Sponsor
Cosponsors (1)
Track HRES 928 in BallotBox360
Get real-time bill updates, floor vote alerts, and AI-powered summaries — all in one app.
Download on iOS Open Web App